Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
The Netherlands Journal of Medicine
|
April 1, 1993
Familial adenomatous polyposis and its clinical surveillance
H F Vasen, G Griffioen, C M Tops, et al.
International Journal of Cancer
|
July 15, 1990
The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands
H F Vasen, G J Offerhaus, F C den Hartog Jager, et al.
International Journal of Cancer
|
February 8, 1996
The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC)
H F Vasen, E A Sanders, B G Taal, et al.
European Journal of Gastroenterology & Hepatology
|
October 19, 1999
Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature
P J Bus, H W Verspaget, J H van Krieken, et al.
Gut
|
September 1, 1994
Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols
H F Vasen, B G Taal, G Griffioen, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 1993
Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease
Y Van de Wal, A Van der Sluys Veer, H W Verspaget, et al.
Familial Cancer
|
July 11, 2006
What is the appropriate screening protocol in Lynch syndrome?
A E de Jong, F M Nagengast, J H Kleibeuker, et al.
Gastroenterology
|
November 1, 1994
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis
C F Sier, H J Vloedgraven, S Ganesh, et al.
Diseases of the Colon and Rectum
|
March 1, 1990
The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands
H F Vasen, G Griffioen, G J Offerhaus, et al.
British Journal of Cancer
|
October 29, 1998
Superoxide dismutases in relation to the overall survival of colorectal cancer patients
A M Janssen, C B Bosman, C F Sier, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
The Netherlands Journal of Medicine
|
April 1, 1993
Familial adenomatous polyposis and its clinical surveillance
H F Vasen, G Griffioen, C M Tops, et al.
International Journal of Cancer
|
July 15, 1990
The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands
H F Vasen, G J Offerhaus, F C den Hartog Jager, et al.
International Journal of Cancer
|
February 8, 1996
The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC)
H F Vasen, E A Sanders, B G Taal, et al.
European Journal of Gastroenterology & Hepatology
|
October 19, 1999
Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature
P J Bus, H W Verspaget, J H van Krieken, et al.
Gut
|
September 1, 1994
Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols
H F Vasen, B G Taal, G Griffioen, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 1993
Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease
Y Van de Wal, A Van der Sluys Veer, H W Verspaget, et al.
Familial Cancer
|
July 11, 2006
What is the appropriate screening protocol in Lynch syndrome?
A E de Jong, F M Nagengast, J H Kleibeuker, et al.
Gastroenterology
|
November 1, 1994
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis
C F Sier, H J Vloedgraven, S Ganesh, et al.
Diseases of the Colon and Rectum
|
March 1, 1990
The value of screening and central registration of families with familial adenomatous polyposis. A study of 82 families in The Netherlands
H F Vasen, G Griffioen, G J Offerhaus, et al.
British Journal of Cancer
|
October 29, 1998
Superoxide dismutases in relation to the overall survival of colorectal cancer patients
A M Janssen, C B Bosman, C F Sier, et al.
Page
of 13